Author name: Dorji

Appointment of Chief for Controlled Substance and Medical Device Division

We are delighted to share that Mr. Kelzang Wangdi has been appointed as the Chief Program Officer of the Controlled Substance and Medical Device Division under the Bhutan Food and Drug Authority (BFDA), Ministry of Health. He brings with him a wealth of experience, having previously served as the Deputy Chief Pharmacist at the National

Appointment of Chief for Controlled Substance and Medical Device Division Read More »

Public Consultation on the Guideline for collaborative registration procedure for pharmaceutical and vaccines 2025

The Medical product division of the Bhutan Food and Drug Authority is pleased to present the draft guideline for collaborative registration procedure for pharmaceutical and vaccines for your comments. This guidance document aims to introduce a reliance registration pathway by relying on MA assessments conducted by reference authorities and institutions like the WHO and promote

Public Consultation on the Guideline for collaborative registration procedure for pharmaceutical and vaccines 2025 Read More »

Public Consultation on Guidelines for Registration of Combination Products

The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft Guideline for Combination Product for your review and feedback.This guidance document is designed to provide technical assistance to medical product suppliers regarding the regulatory requirement for registration of Combination Products (Device+Drug or Drug+Device).We kindly request that you

Public Consultation on Guidelines for Registration of Combination Products Read More »

Public Consultation on Guideline for Post Approval Variation of Medicinal product- Book III

The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft Guideline for Post-Approval Variation of Market Authorization of Medicinal Products for your review and feedback. This guidance document is designed to provide technical assistance to pharmaceutical product suppliers regarding the application procedures for Post-Approval Variation (PAV) submissions.

Public Consultation on Guideline for Post Approval Variation of Medicinal product- Book III Read More »

Public Consultation on the Guideline for Market Authorization of medicinal products via abridged route, 2023- Book II

The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft Guideline for Market Authorization of Medicinal Products via the Abridged Route for your review and feedback. This guidance document is intended to provide technical assistance to medicine suppliers in the preparation and submission of application dossiers for

Public Consultation on the Guideline for Market Authorization of medicinal products via abridged route, 2023- Book II Read More »

Public Consultation on the Guideline for Market Authorization of medicinal products via standard route, 2024- Book I

The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft Guideline for Market Authorization of Medicinal Products via the Standard Route for your review and feedback. This guidance document is designed to assist suppliers in the preparation and submission of application dossiers for obtaining Market Authorization. It

Public Consultation on the Guideline for Market Authorization of medicinal products via standard route, 2024- Book I Read More »

Scroll to Top